Patent intelligence · US
US 7999007
Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
Patent details — US 7999007
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 16, 2011
- Expiration
- Aug 11, 2031
- Applicant
- United Therapeutics Corporation
- Claims
- 26
- CPC classes
- A61K, A61K31/5575, A61K47/02, A61K47/18
Quick answer
US 7999007 (Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same) is held by United Therapeutics Corporation. Status: granted. Granted Aug 16, 2011. Expires Aug 11, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61K, A61K31/5575, A61K47/02, A61K47/18, A61K47/183, A61K9/0019
More from United Therapeutics Corporation
Related pharmaceutical patents in our USPTO index.
-
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted -
US 12419941
Poultry drinking water-based vaccine delivery system and method
granted -
US 12415845
Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
US 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 7999007?
US 7999007 (Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same) is held by United Therapeutics Corporation. Status: granted. Granted Aug 16, 2011. Expires Aug 11, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7999007?
United Therapeutics Corporation is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3,720 pharmaceutical patents for this assignee.
When does US 7999007 expire?
Our index shows an expiration date of Aug 11, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.